DOV Pharmaceutical, Inc.		PIPE
	Aurora Capital sole placement agent

DOV Pharmaceutical, Inc.		Series D Convertible Preferred
	Aurora Capital was a selected dealer on the transaction with a bulge bracket firm

DOV Pharmaceutical, Inc.		Series C Convertible Preferred
	Aurora Capital sole placement agent

DOV Pharmaceutical, Inc. and Elan Corporation		Series B Equity and Debt Financing and Joint Venture
	Aurora Capital sole placement agent

Neurocrine Biosciences and DOV Pharmaceutical, Inc.		Sub-License, Equity Financing Series A Convertible Preferred
	Aurora Capital acted as advisor to DOV

InKine		Private Equity Placement exempt from registration
	Aurora Capital lead co-placement agent

Encysive Pharmaceuticals (formerly, Texas Biotechnology Corp.)		Private Equity Placement exempt from registration
	Aurora Capital co-exclusive placement agent

RegenRx		Private Equity Placement exempt from registration
	Aurora Capital acted as sole placement agency in company offering

Boston Life Sciences		Private Equity Placement exempt from registration
	Aurora Capital assisted another investment bank in a private placement

Cambridge Heart		Private Equity Placement exempt from registration
	Aurora Capital acted as selected dealer

Structural Bioinformatics		Private Placement exempt from registration (Series A and B)
	Aurora Capital acted as exclusive placement agent

ChromaXome Corp		Private Placement exempt from registration
	Aurora Capital acted as exclusive placement agent

Vector Therapeutics		Private Equity Placements exempt from registration (Series A and B)
	Aurora Capital acted as exclusive placement agent

Predict Inc.		Private Equity Placement exempt from registration
	Aurora Capital acted as sole placement agent